Selby_Lancet_CGH_Nov04_CMYK.pdf (133.8 kB)
Download fileThe Lancet Gastroenterology & Hepatology Journal Cover November 1st 2017
Laparoscopic ileocaecal resection versus infiximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. Treatment of patients with ileocaecal Crohn’s disease who have not responded to conventional therapy is commonly scaled up to biological agents, but surgery can also ofer excellent short-term and long-term results. We compared laparoscopic ileocaecal resection with infiximab to assess how they afect health-related quality-of-life.
Funding
Dr Robert Brierley, Dr Heather Van Epps
History
School
- The Arts, English and Drama
Department
- Arts